Dosage and administration
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Angelica Archangelica 3X, Cimicifuga Racemosa 3X, Zincum Gluconicum 6X, Funiculus Umbilicalis Suis 8X, Lymph Node (Suis) 8X, Oophorinum (Suis) 8X, Uterus (Suis) 8X, Glandula Suprarenalis Suis 9X, Thyroidinum Suis 9X, Boricum Acidum 12X, Kreosotum 12X, Mercurius Solubilis 12X, Pulsatilla 12X, Sepia 12X, Calcarea Carbonica 30X, Phosphorus 30X, Sabina 30X, Candida Albicans 30X, Herpes Simplex 1 and 2 Nosode 30X, 60X, Human Papilloma Virus Nosode 30X, 60X.
For temporary relief of menstrual pain and vaginal irritation.
If pregnant or breast-feeding, ask a health care professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in cool, dry place.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
For temporary relief of menstrual pain and vaginal irritation.
Demineralized Water, 25% Ethanol
Distributed by:
BioActive Nutritional, Inc.
1803 N. Wickham Rd.
Melbourne, FL 32935
bioactivenutritional.com
BIOActive Nutritional
GYNETOX
HOMEOPATHIC
1 FL OZ (30 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43857-0165-1 | 2021-11-29 | C162847 | 48780-1 | ba0f9c33-2e62-a910-e053-dadaa90a0b85 | Drug Facts: |
| 43857-0165-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2e62-a910-e053-dadaa90a0b85 | Drug Facts: |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43857-0165 | GYNETOX (ANGELICA ARCHANGELICA, CIMICIFUGA RACEMOSA, ZINCUM GLUCONICUM, FUNICULUS UMBILICALIS SUIS, LYMPH NODE (SUIS), OOPHORINUM (SUIS), UTERUS (SUIS), GLANDULA SUPRARENALIS SUIS, THYROIDINUM SUIS, BORICUM ACIDUM, KREOSOTUM, MERCURIUS SOLUBILIS, PULSATILLA, SEPIA, CALCAREA CARBONICA, PHOSPHORUS, SABINA, CANDIDA ALBICANS, HERPES SIMPLEX 1 AND 2 NOSODE, HUMAN PAPILLOMA VIRUS NOSODE) LIQUID [BIOACTIVE NUTRITIONAL, INC.] | 8 | Legacy NDC | 20211130_8a3e8187-de04-4df0-aac6-cfff6ad5c455.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ANGELICA ARCHANGELICA ROOT | ACTIVE INGREDIENT | DTN01M69SN | 5 | |
| BLACK COHOSH | ACTIVE INGREDIENT | K73E24S6X9 | 5 | |
| BORIC ACID | ACTIVE INGREDIENT | R57ZHV85D4 | 5 | |
| CANDIDA ALBICANS | ACTIVE INGREDIENT | 4D7G21HDBC | 5 | |
| HUMAN HERPESVIRUS 1 | ACTIVE INGREDIENT | 22G38P19RL | 5 | |
| HUMAN HERPESVIRUS 2 | ACTIVE INGREDIENT | 74J6DNH49U | 5 | |
| HUMAN PAPILLOMAVIRUS | ACTIVE INGREDIENT | 23CVL7WF4J | 5 | |
| JUNIPERUS SABINA LEAFY TWIG | ACTIVE INGREDIENT | Z5BEX9K2G1 | 5 | |
| MERCURIUS SOLUBILIS | ACTIVE INGREDIENT | 324Y4038G2 | 5 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE INGREDIENT | 2E32821G6I | 5 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 5 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 5 | |
| SEPIA OFFICINALIS JUICE | ACTIVE INGREDIENT | QDL83WN8C2 | 5 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 5 | |
| SUS SCROFA LYMPH | ACTIVE INGREDIENT | 33A7VYU29L | 5 | |
| SUS SCROFA OVARY | ACTIVE INGREDIENT | S7YTV04R8O | 5 | |
| SUS SCROFA THYROID | ACTIVE INGREDIENT | 6RV024OAUQ | 5 | |
| SUS SCROFA UMBILICAL CORD | ACTIVE INGREDIENT | 118OYG6W3H | 5 | |
| SUS SCROFA UTERUS | ACTIVE INGREDIENT | 2595C75F1P | 5 | |
| WOOD CREOSOTE | ACTIVE INGREDIENT | 3JYG22FD73 | 5 | |
| ZINC GLUCONATE | ACTIVE INGREDIENT | U6WSN5SQ1Z | 5 | |
| ANGELICA ARCHANGELICA ROOT | ACTIVE MOIETY | DTN01M69SN | 5 | |
| BLACK COHOSH | ACTIVE MOIETY | K73E24S6X9 | 5 | |
| BORIC ACID | ACTIVE MOIETY | R57ZHV85D4 | 5 | |
| CANDIDA ALBICANS | ACTIVE MOIETY | 4D7G21HDBC | 5 | |
| HUMAN HERPESVIRUS 1 | ACTIVE MOIETY | 22G38P19RL | 5 | |
| HUMAN HERPESVIRUS 2 | ACTIVE MOIETY | 74J6DNH49U | 5 | |
| HUMAN PAPILLOMAVIRUS | ACTIVE MOIETY | 23CVL7WF4J | 5 | |
| JUNIPERUS SABINA LEAFY TWIG | ACTIVE MOIETY | Z5BEX9K2G1 | 5 | |
| MERCURIUS SOLUBILIS | ACTIVE MOIETY | 324Y4038G2 | 5 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE MOIETY | 2E32821G6I | 5 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 5 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 5 | |
| SEPIA OFFICINALIS JUICE | ACTIVE MOIETY | QDL83WN8C2 | 5 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 5 | |
| SUS SCROFA LYMPH | ACTIVE MOIETY | 33A7VYU29L | 5 | |
| SUS SCROFA OVARY | ACTIVE MOIETY | S7YTV04R8O | 5 | |
| SUS SCROFA THYROID | ACTIVE MOIETY | 6RV024OAUQ | 5 | |
| SUS SCROFA UMBILICAL CORD | ACTIVE MOIETY | 118OYG6W3H | 5 | |
| SUS SCROFA UTERUS | ACTIVE MOIETY | 2595C75F1P | 5 | |
| WOOD CREOSOTE | ACTIVE MOIETY | 3JYG22FD73 | 5 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 5 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43857-0165 | 43857-0165-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 568944d6-2efe-4a6c-8882-05011a8fe69b | 8a3e8187-de04-4df0-aac6-cfff6ad5c455 | 2021-11-29 | Warnings | 568944d6-2efe-4a6c-8882-05011a8fe69b 8a3e8187-de04-4df0-aac6-cfff6ad5c455 |
Adverse event summaries are temporarily unavailable. Other product information remains available.